ShiraTronics, a clinical-stage medical device company developing neurostimulation therapies for chronic migraine patients, ...

Shiratronics Inc. raised $66 million in an oversubscribed series B financing round to support completion of its recently ...

Expert Rev Clin Pharmacol. 2013;6(3):271-288. Triptans are highly effective for short-term treatment of acute migraine attacks. They are effective in MA or MO, but are not intended for use in ...

How should she be evaluated and treated? What is the probable migraine type and the drug of choice for its treatment and long-term management?

Considering Botox for migraine but wondering if it'll change your face? Discover what it can and can't do, plus learn about potential side effects, benefits, and outcomes.

ShiraTronics announced today that it closed a $66 million Series B financing round to support its Migraine Therapy System.

The funding will support the trial, premarket approval application and initial commercial launch of a system that could ...

Migraine is characterised by a wide spectrum of clinical symptoms, including severe and persistent headaches often ...

This article examines the difference between migraine and tension headaches and their causes, symptoms, and treatment options. The cause of migraine is not fully understood but is believed to ...

TMJ disorders are twice as common in women as in men. Because TMJ disorders and migraines have a range of potential causes, it might be necessary to see more than one specialist in hopes of diagnosis ...

Explore the impact of severe migraine and discuss the critical need for conversation between health care providers and ...